Vertex Pharmaceuticals Incorporated (VRTX) ownership: Top institutional holder: Capital World Investors ($11.33B). Insider activity: Net Seller (0 buys, 20 sells). 10 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Capital World Investors | 25368124.00 | $11.33B | 2026-03-31 |
| VANGUARD GROUP INC | 24105823.00 | $10.93B | 2025-12-31 |
| BlackRock, Inc. | 23969517.00 | $10.70B | 2026-03-31 |
| Capital Research Global Investors | 21125964.00 | $9.43B | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 16512810.00 | $7.37B | 2026-03-31 |
| STATE STREET CORP | 11730139.00 | $5.24B | 2026-03-31 |
| JPMORGAN CHASE & CO | 7033156.00 | $3.12B | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 6139621.00 | $2.73B | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-15 | |
| Sell | null | 2026-05-15 |
Back to VRTX overview · VRTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.